Speaker biographies
Mauro Maccarrone University of L’Aquila, Italy
Dr. Enzymology and Bio-Organic Chemistry , is Professor and Chair of Biochemistry at the Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila (Italy). He is also Head of the Lipid Neurochemistry Unit at the European Center for Brain Research – IRCCS Santa Lucia Foundation, Rome. Published numerous highly cited full papers (citations = 22442, h-index = 79 according to Scopus). Invited speaker at more than 110 international congresses, Guest Editor of 16 theme-issues of scientific journals (including Drug Discovery Vol. 76 (2021) by RSC), holder of 9 granted patents. President of the International Cannabinoid Research Society (ICRS) in 2010-2011. Chair of the 2015 Gordon Research Conference on “Cannabinoid Function in the CNS”. Visiting Professor at University of Cambridge in 2017. Received various international awards, including the “2016 Mechoulam Award” for cannabinoid research and the “2020 Tu Youyou Award” for medicinal chemistry. Included by Stanford University in the “2022 World Top 2% Scientists’ List”, and listed among the “Top Italian Scientists”. Lydia Meyer-Turkson Former Sr Director Transactions J&J, USA Lydia Meyer-Turkson is the Global Early Innovation Partnering Leader for Oncology working out of the Boston Innovation Center. In her role, Lydia serves as the key point of contact for the oncology therapeutic area for interactions with the Janssen R&D (JRD) leadership to ensure external innovation opportunities are centrally coordinated and strategically aligned with business priorities. Lydia joined Johnson & Johnson Innovation in January 2022 from Inari Agriculture Inc, a Flagship Ventures company. In her prior role as Vice President of Business Development at Inari, she developed, led and executed the company’s partnering strategy for its gene editing and deep learning technologies in human therapeutics. She worked closely with the Leadership Team, External Innovation, Legal and Patent colleagues to define opportunities aligned to strategic goals and build the business case for partnering. Lydia brings 20 years of broad ranging business development experience working with R & D teams commercializing platform technologies across a range of in and outlicensing transactions, M&A and research collaborations in oncology and rare disease drug discovery, biomarkers and diagnostics. She has worked in the UK, Europe and US with CEO and Executive teams in roles at Horizon Discovery plc (aquired by Perkin Elmer), Evotec GmbH and Epistem plc helping lead business growth. Lydia earned her M.Phil (Masters) in Chemistry at Cardiff University and MBA at Manchester Business School, UK and is a Fellow of the Royal Society of Chemistry and member of the Integrated Chemistry- Biology Research Committee there. Lydia is passionate about socioeconomic diversity and inclusion and has undertaken volunteer roles as reviewer for the L’Oréal Women in Science Awards Committee for Sub-Saharan Africa and the Women in Cancer Research AACR Scholarship Awards Committee.
Made with FlippingBook Learn more on our blog